Protocol No
UAB-19113-NTX-301
Staff Member
Guru Subramanian Guru Murthy
Phase
I
Summary
This project is being done to identify if NTX-301, an oral drug, is safe and tolerable in patients with certain leukemias, and if it has beneficial anti-leukemic effects.
Objective
A phase 1 study of NTX-301 in patients with MDS and AML
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov